Former French Open finalist Sara Errani has been suspended for the use of doping by the International Tennis Federation (ITF). Errani got caught for the use of Letrozol. Letrozol is commonly used for cancer treatments but can also be used to mask the use of doping. That’s why Letrozol is on the list of forbidden substances.
Errani, former World No. 5 and now World No. 98, got caught after a random out-of-competition doping check in February 2017.
Statement from Sara Errani
According to the statement of Errani on Twitter, traces of the forbidden substance got into her body after a dinnerparty at her mother’s place. Her mother, Fulvia, uses Letrozol pro actively after she got diagnosed several times with cancer in 2005.
Fulvia errani says that she keeps Letrozol near her food to remind herself that she has to take the medicine. Because of that, traces of Letrozol have accidentally gotten into the food and ended up in the body of Sara Errani.
The ITF gives Sara Errani the benefit of the doubt and judged that it was an accident. That is why the punishment is only 2 months. The usual suspension for the use of Letrozol is a two to four year suspension.
Next to the suspension, Sara Errani, who gave a statement on social media, also loses her prizemoney and won points that she won between February 16 and June 7, the date of her follow up dopingcheck.
Sara Errani’s career highlights include reaching the finals of the French Open 2012 and with doublespartner and fellow countrywoman, Roberta Vinci, she has won all the Grandslam tournaments between 2012 and 2014.
With the suspension for two months effective immediately, Errani is certain to miss the US Open series. Use Netbet to find out the odds for the winner of the US Open Series!
— Sara Errani (@SaraErrani) 7 augustus 2017